8UWU image
Entry Detail
PDB ID:
8UWU
Title:
EmrE structure in the proton-bound state (WT/L51I heterodimer)
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2023-11-08
Release Date:
2024-05-29
Method Details:
Experimental Method:
Conformers Calculated:
100000
Conformers Submitted:
10
Selection Criteria:
back calculated data agree with experimental NMR data
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:SMR family multidrug efflux protein EmrE
Mutations:L51I
Chain IDs:A
Chain Length:110
Number of Molecules:1
Biological Source:Escherichia coli
Polymer Type:polypeptide(L)
Description:SMR family multidrug efflux protein EmrE
Chain IDs:B
Chain Length:110
Number of Molecules:1
Biological Source:Escherichia coli
Ligand Molecules
Primary Citation
Dynamics underlie the drug recognition mechanism by the efflux transporter EmrE.
Nat Commun 15 4537 4537 (2024)
PMID: 38806470 DOI: 10.1038/s41467-024-48803-2

Abstact

The multidrug efflux transporter EmrE from Escherichia coli requires anionic residues in the substrate binding pocket for coupling drug transport with the proton motive force. Here, we show how protonation of a single membrane embedded glutamate residue (Glu14) within the homodimer of EmrE modulates the structure and dynamics in an allosteric manner using NMR spectroscopy. The structure of EmrE in the Glu14 protonated state displays a partially occluded conformation that is inaccessible for drug binding by the presence of aromatic residues in the binding pocket. Deprotonation of a single Glu14 residue in one monomer induces an equilibrium shift toward the open state by altering its side chain position and that of a nearby tryptophan residue. This structural change promotes an open conformation that facilitates drug binding through a conformational selection mechanism and increases the binding affinity by approximately 2000-fold. The prevalence of proton-coupled exchange in efflux systems suggests a mechanism that may be shared in other antiporters where acid/base chemistry modulates access of drugs to the substrate binding pocket.

Legend

Protein

Chemical

Disease

Primary Citation of related structures